Human IL-7 ELISA Kit
Product Specifications
- Catalogue N°
- 850.040.048 - 1 x 48 Discovery (pre-coated)
850.040.096 - 1 x 96 (pre-coated)
850.040.192 - 2 x 96 (pre-coated) - Assay Range
- 6.25 pg/ml - 200 pg/ml
- Sensitivity
- 3 pg/ml
- Target species
- Human
- Specificity
- Recognizes both natural and recombinant human IL-7
- Incubation
- 2h45
- Sample Type
- Serum, Plasma, Cell culture supernatant
- Sample Size
- 100 µl
- Cross Reaction
- No cross reactivity with other human cytokines
- Kit Content
- Diaclone ELISA Kits include pre-coated strip plates, biotinylated secondary antibody, standards, controls (where applicable), buffers, streptavidin-HRP, TMB, stop reagents and a detailed procedure.
References
- Bikker, A. et al., Arthritis Rheum.,2010; 62(4): 969-77 - Pubmed link
- Butler, M. O. et al., PLoS One,2012; 7(1): e30229 - Pubmed link
- Churchman, S. M. and F. Ponchel, Rheumatology, 2008;47: 753-759 - Pubmed link
- Kang I. et al., J. Imunol., 2004; 173(1): 673 - 681 - Pubmed link
- Levy, Y. et al.,J Clin Invest.,2009;119(4):997-1007 - Pubmed link
- Perales, M-A. et al., Blood,2012;120:4882-4891 - Pubmed link
- Plana, M. et al.,Immunology,2011; 133(3): 318-28 - Pubmed link
- Sereti, I. et al., Blood,2009;113(25): 6304-6314. - Pubmed link
- Sportes, C.et al.,Clin. Cancer Res.,2010;16(2): 727-735 - Pubmed link
- Thiebaut, R. et al.,Clinical Infectious Diseases,2016;62(9): 1178-1185 - Pubmed link
- van Roon, J. A. et al., Ann Rheum Dis.,2003; 62(2): 113-9. - Pubmed link
- van Roon, J. A. et al., Ann Rheum Dis.,2007; 66(5): 664-9. - Pubmed link
BACKGROUND
Human IL-7 (Interleukin 7, IL-7) is a 177-amino acids protein encoded by the IL7 gene located on chromosome 8 (Locus 8q12-13). The active form is glycosylated, weight 25kDa and binds to the IL-7 receptor, a heterodimer consisting of Interleukin-7 receptor alpha (CD127) and common gamma chain receptor CD132) Interleukin-7 is a member of hematopoietic growth factor which plays a role in T-cells development and induces the growth of immature B lymphocytes. IL-7 is secreted by epithelial cells in thymus and bone marrow. It is also produced by intestinal epithelium, keratenocytes, hepatocytes and dendritics cells. It was described to regulate T cell response and proliferation in tissue and serve as a potent regulatory factor.
IL-7 is known to induce the differentiation and proliferation of some haematological malignancies including certain types of leukaemias, lymphomas and may be elevated in lymphopenia. It was also described in breast cancer, common variable immunodeficiency (CVID), HIV (originally presented as a potential eradicating agent), rheumatoid arthritis.
In invasive breast cancer, an aberrant expression of IL-7 and its signaling were described.
In CVID, an elevated plasma levels of circulating IL-7 in a subgroup of patients.
In HIV, it was described that an increase of IL-7 level, produced by dendritic-like cells, enhances a lymphocytes depletion in tissues (lymphopenia).
In RA, IL-7 in synovial fluid activates T cells and macrophages which lead to the inflammation characteristic of RA thought TNFα.
Version 15 - 02.22
For research use only
For any order, the purchaser acknowledges having read and accepted the terms and conditions described on the Diaclone website.